Pia Eiken

发表

Polymorphisms of the peroxisome proliferator-activated receptor γ (PPARγ) gene are associated with osteoporosis

M. Nyegaard, A. Børglum, L. Rejnmark, 2011, Osteoporosis International.

Polymorphisms in the ALOX12 gene and osteoporosis

M. Nyegaard, A. Børglum, L. Rejnmark, 2011, Osteoporosis International.

Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users

R. Eastell, P. Eiken, B. Abrahamsen, 2017, Osteoporosis International.

Clinical fracture risk evaluated by hierarchical agglomerative clustering

P. Vestergaard, C. Kruse, P. Eiken, 2017, Osteoporosis International.

Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective

P. Vestergaard, K. Brixen, P. Eiken, 2015, Osteoporosis International.

Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women.

P. Vestergaard, L. Mosekilde, A. Hermann, 2001, Maturitas.

Predicting mortality and incident immobility in older Belgian men by characteristics related to sarcopenia and frailty

P. Vestergaard, B. Lapauw, S. Goemaere, 2018, Osteoporosis International.

Improving compliance with hormonal replacement therapy in primary osteoporosis prevention.

P. Vestergaard, A. Hermann, J. Gram, 1997, Maturitas.

Optimal age of commencing and discontinuing thiazide therapy to protect against fractures

P. Vestergaard, C. Kruse, P. Eiken, 2016, Osteoporosis International.

Effects of COLIA1 polymorphisms and haplotypes on perimenopausal bone mass, postmenopausal bone loss and fracture risk

P. Vestergaard, P. Eiken, B. Abrahamsen, 2011, Osteoporosis International.

Characteristics of patients who suffer major osteoporotic fractures despite adhering to alendronate treatment: a National Prescription registry study

R. Eastell, P. Eiken, B. Abrahamsen, 2012, Osteoporosis International.